Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Neoplasms (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neoplasms (diagnosis) < Neoplasms (drug therapy) < Neoplasms (epidemiology)  Facettes :

List of bibliographic references indexed by Neoplasms (drug therapy)

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000075 (2021) Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte]Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
000659 (2021) Sreedhar Amere Subbarao [Inde]Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.
000679 (2021) Davide Colombi [Italie] ; Flavio Cesare Bodini [Italie] ; Nicola Morelli [Italie] ; Mario Silva [Italie] ; Gianluca Milanese [Italie] ; Luigi Cavanna [Italie] ; Emanuele Michieletti [Italie]COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
001271 (2020) Tamara Nawar [États-Unis] ; Sejal Morjaria [États-Unis] ; Anna Kaltsas [États-Unis] ; Dhruvkumar Patel [États-Unis] ; Rocio Perez-Johnston [États-Unis] ; Anthony F. Daniyan [États-Unis] ; Sham Mailankody [États-Unis] ; Rekha Parameswaran [États-Unis]Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
001483 (2020) Elisa Maria Stroppa [Italie] ; Ilaria Toscani [Italie] ; Chiara Citterio [Italie] ; Elisa Anselmi [Italie] ; Elena Zaffignani [Italie] ; Mauro Codeluppi [Italie] ; Luigi Cavanna [Italie]Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
001545 (2020) Peng Liu [France] ; Liwei Zhao [France] ; Gladys Ferrere [France] ; Carolina Alves-Costa-Silva [France] ; Pierre Ly [France] ; Qi Wu [France] ; Ai-Ling Tian [France] ; Lisa Derosa [France] ; Laurence Zitvogel [France] ; Oliver Kepp [France] ; Guido Kroemer [France, République populaire de Chine, Suède]Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
001689 (2020) Shaw M. Akula [États-Unis] ; Stephen L. Abrams [États-Unis] ; Linda S. Steelman [États-Unis] ; Saverio Candido [Italie] ; Massimo Libra [Italie] ; Kvin Lerpiriyapong [États-Unis] ; Lucio Cocco [Italie] ; Giulia Ramazzotti [Italie] ; Stefano Ratti [Italie] ; Matilde Y. Follo [Italie] ; Alberto M. Martelli [Italie] ; William L. Blalock [Italie] ; Manuela Piazzi [Italie] ; Giuseppe Montalto [Italie] ; Melchiorre Cervello [Italie] ; Monica Notarbartolo [Italie] ; Jorg Basecke [Allemagne] ; James A. Mccubrey [États-Unis]Cancer therapy and treatments during COVID-19 era.
001897 (2020) Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
001A16 (2020) Ana Fernández-Cruz [Oman] ; Belén Ruiz-Antorán [Espagne] ; Ana Mu Oz-G Mez [Espagne] ; Aránzazu Sancho-L Pez [Espagne] ; Patricia Mills-Sánchez [Espagne] ; Gustavo Adolfo Centeno-Soto [Espagne] ; Silvia Blanco-Alonso [Espagne] ; Laura Javaloyes-Garachana [Espagne] ; Amy Galán-G Mez [Espagne] ; Ángela Valencia-Alijo [Espagne] ; Javier G Mez-Irusta [Espagne] ; Concepci N Payares-Herrera [Espagne] ; Ignacio Morrás-Torre [Espagne] ; Enrique Sánchez-Chica [Espagne] ; Laura Delgado-Téllez-De-Cepeda [Espagne] ; Alejandro Callejas-Díaz [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Elena Mú Ez-Rubio [Espagne] ; Cristina Avenda O-Solá [Espagne]A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
001A19 (2020) Effat Davoudi-Monfared [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran] ; Mahboubeh Hajiabdolbaghi [Iran] ; Mohamadreza Salehi [Iran] ; Ladan Abbasian [Iran] ; Hossein Kazemzadeh [Iran] ; Mir Saeed Yekaninejad [Iran]A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Neoplasms (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Neoplasms (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neoplasms (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021